Similar Search Results

Competition between generic and brand name drugs : new evidence from the U.S. pharmaceutical market

Cavaliere, Alberto; Moayedizadeh, Ashin - 2022

Persistent link: https://www.econbiz.de/10014232582

Branded vs. generic drugs : the role of self-perceived seriousness of disease

Sestino, Andrea; Amatulli, Cesare - In: International journal of pharmaceutical and healthcare … 16 (2022) 1, pp. 22-39

Persistent link: https://www.econbiz.de/10012886098

The competitive impact of branded generic medicine in a developing country

Álvarez, Roberto; González, Aldo; Fernández, Sebastian - 2019

Persistent link: https://www.econbiz.de/10012659663

The "generic competition paradox" revisited

Saha, Atanu; Xu, Yong - In: International journal of the economics of business 28 (2021) 3, pp. 363-375

Persistent link: https://www.econbiz.de/10012697876

Delayed entry settlements at the patent office

Hovenkamp, Erik; Lemus, Jorge A. - In: International review of law and economics 54 (2018), pp. 30-38

Persistent link: https://www.econbiz.de/10012058326

Drug detailing and doctors' prescription decisions : the role of information content in the caf of competitive entry

Kappe, Eelco; Stremersch, Stefan - In: Marketing science : the marketing journal of the … 35 (2016) 6, pp. 915-933

Persistent link: https://www.econbiz.de/10011617439

The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms

Panattoni, Laura E. - In: Journal of health economics 30 (2011) 1, pp. 126-145

Persistent link: https://www.econbiz.de/10009247369

Strategies used to defend pharmaceutical brands from generics

Wilkie, Dean C. H.; Johnson, Lester W.; White, Lesley - In: European journal of marketing : EJM 46 (2012) 9, pp. 1195-1214

Persistent link: https://www.econbiz.de/10009661664

Pseudo-generic products and barriers to entry in pharmaceutical markets

Kong, Ying; Seldon, James R. - In: Review of industrial organization : RIO 25 (2004) 1, pp. 71-86

Persistent link: https://www.econbiz.de/10002260045

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...

Persistent link: https://www.econbiz.de/10012802183

1
2
3
4
5
6
7
8
9
10
Next
Last